Literature DB >> 16388608

Site-specific gene modification by PNAs conjugated to psoralen.

Ki-Hyun Kim1, Peter E Nielsen, Peter M Glazer.   

Abstract

DNA-binding molecules, including triplex-forming oligonucleotides (TFOs) and peptide nucleic acids (PNAs), can be utilized to introduce site-specific mutations or to promote recombination at selected genomic sites. To further evaluate the utility of PNAs for site-specific gene modification, we tested dimeric bis-PNAs conjugated to psoralen. These PNAs are designed to form a triplex-invasion complex within the supF reporter gene in an episomal shuttle vector and to direct site-specific photoadduct formation by the conjugated psoralen. The psoralen-bis-PNA conjugate was found to direct photoadduct formation to the intended 5'-TpA base step next to the PNA-binding site, and the photoadduct formation efficiency displayed both concentration and UVA irradiation dependence. The effect of PNA-targeted photoadducts in a mammalian system was tested by SV40-based shuttle vector assay. After in vitro binding, we found that photoadducts directed by PNAs conjugated to psoralen-induced mutations at frequencies in the range of 0.46%, 6.5-fold above the background. In a protocol for intracellular gene targeting in the episomal shuttle vector, the psoralen-PNA-induced mutation frequency was 0.13%, 3.5-fold higher than the background. Most of the induced mutations were deletions and single-base-pair substitutions at or adjacent to the targeted PNA-binding and photoadduct-formation sites. When the results are taken together, they demonstrate the ability of bis-PNAs conjugated with psoralen to mediate site-specific gene modification, and they further support the development of PNAs as tools for gene-targeting applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16388608     DOI: 10.1021/bi051379a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Targeted gene correction using psoralen, chlorambucil and camptothecin conjugates of triplex forming peptide nucleic acid (PNA).

Authors:  Henrik Birkedal; Peter E Nielsen
Journal:  Artif DNA PNA XNA       Date:  2011-01

Review 2.  Genome engineering with zinc-finger nucleases.

Authors:  Dana Carroll
Journal:  Genetics       Date:  2011-08       Impact factor: 4.562

3.  Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids.

Authors:  Erica B Schleifman; Ranjit Bindra; Jean Leif; Jacob del Campo; Faye A Rogers; Pradeep Uchil; Olaf Kutsch; Leonard D Shultz; Priti Kumar; Dale L Greiner; Peter M Glazer
Journal:  Chem Biol       Date:  2011-09-23

4.  Inducible alkylation of DNA by a quinone methide-peptide nucleic acid conjugate.

Authors:  Yang Liu; Steven E Rokita
Journal:  Biochemistry       Date:  2012-01-24       Impact factor: 3.162

Review 5.  Oligo/polynucleotide-based gene modification: strategies and therapeutic potential.

Authors:  R Geoffrey Sargent; Soya Kim; Dieter C Gruenert
Journal:  Oligonucleotides       Date:  2011-03-21

6.  Directing Quinone Methide-Dependent Alkylation and Cross-Linking of Nucleic Acids with Quaternary Amines.

Authors:  Mark A Hutchinson; Blessing D Deeyaa; Shane R Byrne; Sierra J Williams; Steven E Rokita
Journal:  Bioconjug Chem       Date:  2020-04-23       Impact factor: 4.774

7.  Single-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognition.

Authors:  Raman Bahal; Elias Quijano; Nicole A McNeer; Yanfeng Liu; Dinesh C Bhunia; Francesco Lopez-Giraldez; Rachel J Fields; William M Saltzman; Danith H Ly; Peter M Glazer
Journal:  Curr Gene Ther       Date:  2014       Impact factor: 4.391

8.  Targeted genome modification via triple helix formation.

Authors:  Adele S Ricciardi; Nicole A McNeer; Kavitha K Anandalingam; W Mark Saltzman; Peter M Glazer
Journal:  Methods Mol Biol       Date:  2014

Review 9.  Nanotechnology for delivery of peptide nucleic acids (PNAs).

Authors:  Anisha Gupta; Raman Bahal; Meera Gupta; Peter M Glazer; W Mark Saltzman
Journal:  J Control Release       Date:  2016-01-08       Impact factor: 9.776

10.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors:  Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.